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EDITORIAL 
Endocrinology of Acne 
The persistence of acne in a woman fi'equently evokes a 
concern for the presence of a hormonal abnormality to explain 
it, especially when the disease is unusually chronic and recal-
citrant to treatment. The perception of a possible association is 
not difficult to understand, as acne activity often fluctuates in 
relation to the menstrual cycle and can be a sign of hyperan-
drogenism in ovarian and adrenal disorders. In the latter cir-
cumstances, though, there are almost always other manifesta-
tions of androgen excess, such as hirsutism and/ or irregular 
menses, particularly oligomenorrhea. 
A still unanswered question, however, has been whether acne, 
unaccompanied by hirsutism, menstrual irregularities, or other 
signs of virilism, can nonetheless be attended by endocrine 
dysfunction of a sufficient degree to aggravate and maintain the 
acne at a higher level of activity. Studies trying to demonstrate 
such a relationship have not been wanting, and, in fact, extend 
back more than four decades to the time when attempts were 
made to show (unsuccessfully) that urine extracts fi'om acne 
patients were more active than normal when bioassayed for 
their androgenic effects in animals. 
In more recent years, the advent of new and improved 
techniques for assaying hormones in biologic fluids has rekin-
dled an interest in the possibility of detecting hormonal abnor-
malities in acne. From the results of such studies, an unequiv-
ocal picture of a consistent pattern of abnormal endocrine 
function has not emerged. To appreciate the uncertainty in this 
regard, one has only to peruse the various reports of the 
measw·ement of serum or plasma testosterone in women with 
acne in whom levels have been found to be normal (most often), 
slightly increased (less often), or increased (least often). There 
are similarly variable findings for the measurement of most 
other hormones. 
What accounts for the discrepant findings among investiga-
tors? Some factors can be cited, such as too few patients studied, 
inadequate or inappropriate control groups, failure to indicate 
the presence or absence of other virilizing signs or symptoms, 
lack of information concerning time of blood sampling in rela-
tion to the menstrual cycle, and imprecision or insensitivity of 
analytical techniques. Inattention to one or more of these 
factors has undoubtedly been responsible, in part, for the dis-
parity of the results obtained. 
In this issue of the Jow-na), Lucky and her associates have 
reported on an extensive survey of the measw·ement of anill·o-
gens and anill·ogen precw-sors in the blood of women with acne. 
They have sorted out patients found to have both acne and 
hirsutism from those with acne alone and those with hirsutism 
alone. The nonacne control group of women were age-matched 
and examined to assure the absence of either of these physical 
characteristics. These investigators' findings show clearly 
enough that in women with acne alone, as compared to nonacne 
subjects, there are statistically significant increases in virtually 
all plasma anill·ogens such as testosterone and dehydroepian-
ill·osterone sulfate, and in androgen precursors such as 17 o:-
hydroxyprogesterone. However, it should be stressed that these 
are differences of mean levels, and that with each hormone 
examined there is considerable overlap of individual values 
between the acne and normal groups. For example, only 12% of 
the acne patients actually had testosterone levels that exceeded 
the upper limit of normal. Even though an important observa-
tion was made-that the fi'ee or unbound level of testosterone, 
that small fraction of the circulating hormone which is the 
active form that enters the peripheral cell, was abnormally 
increased in 25% of the acne subjects-that still left 75% of 
patients who had normal levels. 
In fact, for each of the hormones tested, there were always 
more acne patients with normal values than with abnormal 
values. The obvious thought, then, is that there may be two 
types of acne in women, i.e., endocrine acne and nonendocrine 
acne, despite the absence of signs other than acne to indicate a 
hyperanill·ogenic milieu. But there are no clinical clues that 
would allow us at the present time to distinguish one such 
group from the other, nor is there incontrovertible evidence 
that correction of abnormal hormone levels will reduce acne 
activity. Marynick and coworkers reported at the Endocrine 
Society meeting in 1981 that a high proportion of women and 
men with acne have increased serum dehyill·oepianill·osterone 
sulfate levels and that treatment with dexamethasone in very 
small doses, 0.25-0.375 mg daily, led to improvement of the 
acne in many cases. However, no placebo-treated group of 
patients was studied. 
One might also speculate whether lowering of normal anill·o-
gen levels by endocrine treatment to still lower levels might be 
just as beneficial as when there are abnormalities to begin with. 
Complicating any interpretation of the mechanism of such 
responses is the matter of peripheral metabolism by the skin of 
the hormones reaching it. One can imagine, for example, a 
circumstance in which an acne patient with active skin metab-
olism of anill·ogens but with normal blood androgen levels 
might actually be in greater hormonal "imbalance" than an 
individual with heightened androgen blood levels but with 
relative anill·ogen insensitivity of the skin. Future research 
endeavors should be directed not only to a further delineation 
of the scope of endogenous hormonal abnormalities in patients 
with acne but also to a knowledge of how these relate to 
peripheral cellular events. Only then is it likely that hormonal 
therapy can be targeted in a more rational manner so as to 
result in a reasonably predictable clinical response. 
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